GeneDx (WGS) Revenue & Revenue Breakdown
GeneDx Revenue Highlights
Latest Revenue (Y)
$202.57M
Latest Revenue (Q)
$70.51M
Main Segment (Y)
Diagnostic Test
GeneDx Revenue by Period
GeneDx Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $202.57M | -13.69% |
| 2022-12-31 | $234.69M | 10.60% |
| 2021-12-31 | $212.19M | 18.33% |
| 2020-12-31 | $179.32M | -8.59% |
| 2019-12-31 | $196.17M | - |
GeneDx generated $202.57M in revenue during NA 2023, up -13.69% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
GeneDx Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $70.51M | 12.96% |
| 2024-03-31 | $62.42M | 8.72% |
| 2023-12-31 | $57.42M | 7.72% |
| 2023-09-30 | $53.30M | 9.44% |
| 2023-06-30 | $48.71M | 12.90% |
| 2023-03-31 | $43.14M | -29.68% |
| 2022-12-31 | $61.35M | -26.29% |
| 2022-09-30 | $83.23M | 130.13% |
| 2022-06-30 | $36.17M | -32.95% |
| 2022-03-31 | $53.94M | -6.68% |
| 2021-12-31 | $57.80M | 33.87% |
| 2021-09-30 | $43.18M | -7.87% |
| 2021-06-30 | $46.87M | -27.00% |
| 2021-03-31 | $64.20M | 0.38% |
| 2020-12-31 | $63.96M | 65.66% |
| 2020-09-30 | $38.61M | - |
GeneDx generated $70.51M in revenue during Q2 2024, up 12.96% compared to the previous quarter, and up 163.46% compared to the same period a year ago.
GeneDx Revenue Breakdown
GeneDx Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 22 |
|---|---|
| Diagnostic Test | $227.33M |
| Product and Service, Other | $7.36M |
GeneDx's latest annual revenue breakdown by segment (product or service), as of Dec 22: Diagnostic Test (96.86%), and Product and Service, Other (3.14%).
Quarterly Revenue by Product
| Product/Service | Jun 24 |
|---|---|
| Diagnostic Test, Self Pay | $692.00K |
| Diagnostic Test | $69.44M |
| Product and Service, Other | $1.07M |
| Diagnostic Test, Third Party Insurance | $52.05M |
| Diagnostic Test, Institutional Customers | $16.70M |
GeneDx's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Diagnostic Test (49.62%), Diagnostic Test, Third Party Insurance (37.19%), Diagnostic Test, Institutional Customers (11.93%), Product and Service, Other (0.77%), and Diagnostic Test, Self Pay (0.49%).
GeneDx Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| PRVA | Privia Health Group | $1.66B | $422.33M |
| BBLN | Babylon | $1.11B | $311.12M |
| CERT | Certara | $354.34M | $93.31M |
| CPSI | TruBridge | $326.65M | $82.71M |
| HSTM | HealthStream | $279.06M | $71.56M |
| DH | Definitive Healthcare | $251.41M | $63.70M |
| WGS | GeneDx | $202.57M | $70.51M |
| NRC | National Research | $148.58M | $35.31M |
| ETAO | ETAO | $58.06M | - |
| HCTI | Healthcare Triangle | $33.20M | $2.98M |
| EUDA | EUDA Health | $3.71M | $1.11M |
| AKLI | Akili | $1.68M | $383.00K |
| ACON | Aclarion | $75.40K | $10.97K |
WGS Revenue FAQ
What is GeneDx’s yearly revenue?
GeneDx's yearly revenue for 2023 was $202.57M, representing a decrease of -13.69% compared to 2022. The company's yearly revenue for 2022 was $234.69M, representing an increase of 10.60% compared to 2021. WGS's yearly revenue for 2021 was $212.2M, representing an increase of 18.33% compared to 2020.
What is GeneDx’s quarterly revenue?
GeneDx's quarterly revenue for Q2 2024 was $70.51M, a 12.96% increase from the previous quarter (Q1 2024), and a 44.77% increase year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $62.42M, a 8.72% increase from the previous quarter (Q4 2023), and a 44.70% increase year-over-year (Q1 2023). WGS's quarterly revenue for Q4 2023 was $57.42M, a 7.72% increase from the previous quarter (Q3 2023), and a -6.41% decrease year-over-year (Q4 2022).
What is GeneDx’s revenue growth rate?
GeneDx's revenue growth rate for the last 3 years (2021-2023) was -4.54%, and for the last 5 years (2019-2023) was 3.26%.
What are GeneDx’s revenue streams?
GeneDx's revenue streams in c 22 are Diagnostic Test, and Product and Service, Other. Diagnostic Test generated $227.33M in revenue, accounting 96.86% of the company's total revenue Product and Service, Other generated $7.36M in revenue, accounting 3.14% of the company's total revenue
What is GeneDx’s main source of revenue?
For the fiscal year ending Dec 22, the largest source of revenue of GeneDx was Diagnostic Test. This segment made a revenue of $227.33M, representing 96.86% of the company's total revenue.